Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2019 Jan 29;9:837. doi: 10.1038/s41598-018-37139-9

Tsc1 ablation in Prx1 and Osterix lineages causes renal cystogenesis in mouse

Zhixiang Wu 1, Hongguang Wu 1, Shafiquzzaman Md 1, Guo Yu 1, Samy L Habib 2, Baojie Li 1, Jing Li 3,✉
PMCID: PMC6351533  PMID: 30696882

Abstract

Tuberous Sclerosis Complex (TSC) is caused by mutations in TSC1 or TSC2, which encode negative regulators of the mTOR signaling pathway. The renal abnormalities associated with TSC include angiomyolipoma, cysts, and renal cell carcinoma. Here we report that specific ablation of Tsc1 using the mesenchymal stem cell-osteoblast lineage markers induced cystogenesis in mice. Using Rosa-tdTomato mice, we found that Prx1- or Dermo1-labeled cells were present in the nephron including glomerulus but they were not stained by markers for podocytes, mesangial cells, endothelial cells, or proximal or loop of Henle tubular cells, while Osx is known to label tubular cells. Tsc1 deficiency in Prx1 lineage cells caused development of mild cysts that were positive only for Tamm-Horsfall protein (THP), a loop of Henle marker, while Tsc1 deficiency in Osx lineage cells caused development of cysts that were positive for Villin, a proximal tubular cell marker. On the other hand, Tsc1 deficiency in the Dermo1 lineage did not produce detectable phenotypical changes in the kidney. Cyst formation in Prx1-Cre; Tsc1f/f and Osx-Cre; Tsc1f/f mice were associated with increase in both proliferative and apoptotic cells in the affected tissue and were largely suppressed by rapamycin. These results suggest that Prx1 and Osx lineages cells may contribute to renal cystogenesis in TSC patients.

Introduction

Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease caused by mutations in TSC1 or TSC2. TSC patients usually display overgrowth in brain, kidney, lung, eye, and skin1–3. If left untreated, nearly 40% of TSC patients die by the age of 35 years, mainly due to renal failure or hemorrhage4. In kidney, TSC symptoms include angiomyolipoma, cysts, and rarely renal cell carcinoma. Angiomyolipomas are of mesenchymal origin and composed of varying proportions of vascular cells, smooth muscle cells, and fat cells, whereas cysts are of epithelial origin5. Genetic ablation of one allele of Tsc1 or Tsc2 in mouse recapitulates the phenotypes of TSC patients6.

Tsc1 and Tsc2 encode two negative regulators of the mTOR signaling pathway. mTOR signaling plays important roles in the development and homeostasis of multiple tissues and organs. The mTOR pathway consists of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTORC1 is composed of mTOR and regulatory associated protein of mTOR (Raptor), while mTORC2 is composed of mTOR and rapamycin independent companion of mTOR (Rictor). Rapamycin-sensitive mTORC1 activation promotes cell proliferation and growth in size. Rapamycin-insensitive mTORC2 controls the cytoskeleton and cell shape. Growth factors activate the PI3K-Akt pathway, which deactivates the heterodimer complex of TSC1 and TSC2, resulting in activation of mTORC1 through Ras-related small GTPase (Rheb). Activated mTORC1 promotes transcription and protein translation to promote cell proliferation and growth via phosphorylation of both p70S6K and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Brook-Carter et al. in 1994 discovered that deletion of TSC2 was associated with severe infantile polycystic kidney disease7. Later, a series of reports suggested that misregulation of mTOR signaling would produce polycystic kidney disease8–12. In TSC animal models, renal cysts and cell hyperproliferation are detected. Pema. et al. reported that mTORC1-mediated inhibition of polycystin-1 expression might underlie renal cyst formation13. On the other hand, a recent study suggested that TSC-induced tumorigenesis was independent of mTOR pathway activation14.

Kidney growth is regulated by mTOR signaling15. The main structure and function units of kidney are the nephrons, which are composed of blood-filtrating renal corpuscle and renal tubules. The renal corpuscle is made of glomerulus and the surrounding Bowman’s capsule. It is estimated that renal tubular cells may have 16 different types of epithelial cells. Developmentally, kidney is derived from the intermediate mesoderm. While Wolffian duct-derived epithelial cells form the ducts, Six2-positive mesenchymal cells form the nephrons and Foxd1-positive cells give rise to the stromal cells in the kidney16. Both Six2-positive nephrons and Foxd1-positive interstitial cells are derived from Osr1-positive progenitor cells prior to embryonic day (E) 10.517.

In this study, we showed that two mesoderm-derived mesenchymal stem cell (MSC) markers, Prx1 and Dermo1, could label previously unidentified renal stromal cells. A previous study indicated that Osterix (Osx), a transcription factor essential for osteoblast differentiation, labeled renal tubular cells18–20. We deleted Tsc1 in Prx1, Dermo1, and Osx positive cells using corresponding Cre mouse lines and found significant abnormalities in the kidneys of Prx1-Cre; Tsc1f/f and Osx-Cre; Tsc1f/f mouse lines but not Dermo1-Cre; Tsc1f/f mice. Prx1-Cre; Tsc1f/f mice had cysts derived from loop of Henle, whereas Osx-Cre; Tsc1f/f mice had cysts formed from proximal tubules. The overgrowth phenotypes were likely caused by increased cell proliferation, which could be rescued by intraperitoneal injection of rapamycin.

Result

Lineage tracing identified Prx1-expressing cells in mouse kidney

MSCs harbor the potentials to differentiate into many cell types, especially osteoblasts, chondrocytes, and adipocytes. Prx1 and Dermo1 are generally used as genetic marks for MSCs in skeletal studies21–24. We have previously established Tsc1 knockout mice using Prx1-Cre, Dermo1-Cre, and Osx-Cre mouse lines to study mTOR signaling in skeletal growth and development25. Interestingly, we found that the kidneys of these mice also displayed some anomalies, suggesting that these markers may also label kidney cells.

We first traced Prx1-expressing cells using Prx1-Cre; Rosa-tdTomato mice to study whether Prx1 lineage cells existed in the kidney. Fluorescent microscopy revealed Tomato-positive cells in the cortex and medulla including glomerulus and tubular regions in adult mice (Fig. 1A). Immuno-staining revealed that Prx1 lineage cells were negative for Villin, a proximal tubular cell marker; THP, a loop of Henle marker; CD31, an endothelial marker; WT-1, a podocyte marker; Laminin α5, an epithelial marker; and vimentin, a mesangial marker (Fig. 1B). These results suggest that Prx1 lineage constitute a group of stromal cells/fibroblasts in the kidney.

Figure 1.

Figure 1

Open in a new tab

Prx1 marks a population of cells in mouse kidney. (A) Microscopic images of kidney sections of Prx1-Cre; tdTomato mice. (B) Immunofluorescent staining on Prx1-Cre; tdTomato mouse kidney sections revealed that Prx1 linage renal cells were negative for the tested markers of different renal cell types. (C) DT was injected into Prx1-Cre; iDTR mice daily for different periods of time as indicated to deplete Prx1 lineage cells. Moue kidneys were sectioned and stained with H-E. (D) Quantitative analysis of tubular cell numbers. N = 3. *P < 0.05; **P < 0.001 when compared to the control mice.

To validate these findings, we crossed Rosa-iDTR mice with Prx1-Cre mice to generate Prx1-Cre; iDTR mice, which could be used to deplete the Cre-expressing cells26–28. Diphtheria toxin (DT) was injected daily for 1, 3, and 5 days to Prx1-Cre; iDTR mice and iDTR mice. Although the gross structure of the kidney was not altered in DT-treated mutant mice (Fig. 1C), the number of glomerulus was significantly reduced. Quantitation of tubular cells separation (the ratio between the number of tubular nucleus and renal cortex area) revealed that the average tubular cell number declined as well (Fig. 1D). Taken together, the results indicate that Prx1 lineage cells were important component of the nephrons.

Mice with Tsc1 deletion in Prx1-expressing cells showed mild renal cysts

To understand the function of mTOR activation in Prx1 lineage cells of kidney, we crossed Tsc1f/f mice with Prx1-Cre mice to generate Prx1-Cre; Tscf1f/f mice. Immunohistological staining for p-S6, an indicator for mTOR pathway activation, revealed that ablation of Tsc1 in Prx1 lineage cells resulted in an increase in mTOR activation in some of the renal cells (Fig. 2A). At the age of 2 months, the Prx1-Cre; Tsc1f/f mice exhibited an increase in the size and weight of the kidneys compared to the control littermates (Fig. 2B). Histological examination revealed several cysts in the kidney (Fig. 2C), yet, no cyst was detected in 1-month-old mice (Fig. 2D), suggesting that the cysts were formed during mouse rapid growth period. While normal mice showed no cysts, the average cyst size and the percentage of cystic area occupying the total kidney cortex area indicated a mild polycystic kidney condition in the mutant mice (Fig. 2E). On the other hand, Prx1-Cre; Tsc1f/f mice showed normal number and circumference of glomeruli (Fig. 2F,G).

Figure 2.

Figure 2

Open in a new tab

Conditional knockout of Tsc1 in the Prx1 lineage resulted in the development of mTORC1-dependent cysts. (A) Prx1-Cre; Tsc1f/f mouse kidney sections showed increased p-S6 signals. (B) Prx1-Cre; Tsc1f/f mice showed enlarged kidneys that were rescued by rapamycin injection. Left panels: images of kidneys from different mouse lines. Right panel: the weights of the kidneys from different mouse lines. (C) H-E staining (40x) of the kidney sections of Prx1-Cre; Tsc1f/f and control mice treated with rapamycin or vehicle. (D) H-E staining showed that 1- month-old mice did not develop cysts. (E) Images of kidney sections of Prx1-Cre; Tsc1f/f and control mice treated with rapamycin or vehicle. (F) Cystic index of Prx1-Cre; Tsc1f/f and control mice treated with rapamycin or vehicle. The cystic index for control mice is 0. (G) Quantitative analysis of glomerulus separation. N = 3. *P < 0.05; **P < 0.001 when compared to the control mice.

Immuno-staining revealed that all the cysts were positive only for THP, a loop of Henle marker, but negative for Villin, CD31, WT-1, and vimentin (Fig. 3A), indicating that the cysts were originated from the loop of Henle cells. Since Prx1 lineage cells were negative for THP themselves, these results suggest that Prx1 lineage cells may induce cyst formation via cell-cell contact or secretion of pro-growth factors.

Figure 3.

Figure 3

Open in a new tab

Prx1-Cre; Tsc1f/f mouse kidney samples showed an increase in proliferating cells and apoptotic cells compared to control mice. (A) Immunofluorescent staining for different renal cell markers at the cyst region of Prx1-Cre; Tsc1f/f mouse revealed that the cysts were mainly positive for THP. (B) Representative images of Ki67-stained kidney sections. (C) Quantitative analysis of Ki67 positive cells. N = 3. *P < 0.05; **P < 0.001 when compared to the control mice. (D) Representative images of TUNEL stained kidney sections. (E) Quantitative analysis of TUNEL positive cells. N = 3. *P < 0.05; **P < 0.001 when compared to the control mice.

Rapamycin prevented cyst formation in Prx1-Cre; Tsc1f/f mice

Ablation of Tsc1 in Prx1-expressing cells resulted in mTORC1 activation. To assess the role of mTORC1 in cyst development and expansion, rapamycin was injected intraperitoneally into control and mutant mice for 4 weeks. Rapamycin injection resulted in a modest decrease in the body weights of control and mutant mice compared to vehicle-injected littermates (data not shown). At the end of the injection, the kidneys were harvested and analyzed. In rapamycin-treated Prx1-Cre; Tsc1f/f mice, the morphological abnormalities of the kidney were rescued (Fig. 2B). A continuous scanning of H-E stained coronal sections of rapamycin-treated Prx1-Cre; Tsc1f/f mouse kidney at 400 times magnification revealed only some tiny cysts (Fig. 2C and lower panels of Fig. 2E). The average size of the cysts and the cystic area/cortex tissue area were reduced in rapamycin-treated Prx1-Cre; Tsc1f/f mice (Fig. 2F,G). Collectively, these results indicated that rapamycin inhibited cysts growth and alleviated kidney abnormalities of Prx1-Cre; Tsc1f/f mice. The results also suggested that cystogenesis was largely caused by mTORC1 activation in Prx1-Cre; Tsc1f/f mice.

Prx1-Cre; Tsc1f/f mice showed an increase in both cell proliferation and apoptosis

Kidney cyst formation can be caused by increased cell proliferation, decreased apoptosis, or both. We stained the kidney sections with anti-Ki67 antibodies and quantified the ratio of Ki67-positive nuclei to the total number of DAPI-stained nuclei (Fig. 3B). The result revealed an increase in the number of proliferative cells in the kidney of Prx1-Cre; Tsc1f/f mice compared to controls (Fig. 3C). Quantitative analysis of TUNEL-stained sections revealed a higher percentage of TUNEL-positive cells, after normalized to DAPI-stained nuclei, in Prx1-Cre; Tsc1f/f kidney than controls (Fig. 3D,E). These results suggest that enhanced cell proliferation underlies cystogenesis in Prx1-Cre; Tsc1f/f mice, while increased apoptosis may be a secondary effect of increased cell proliferation.

Osx-Cre; Tsc1f/f mice showed cystogenesis that was alleviated by rapamycin

Osterix is a zinc finger protein essential for osteoblast differentiation from MSCs. Although it is considered as an osteoblast-specific transcription factor, it was also found expressed in the kidney29. The expression of Osterix is high at p4 but low at E17.5 or p21. The signals were detectable mainly in the juxtamedullary nephrons and proximal tubules at low levels and the descending loop of Henle at high levels. Moreover, heterozygous deletion of Osx resulted in increased IL6 expression and enhanced inflammatory responses upon renal injuries30. These results suggest that Osx is expressed in the kidney and plays a role in kidney injury and repair.

We generated Osx-Cre; Tsc1f/f mice by crossing Osx-Cre mice with Tsc1f/f mice. The up-regulation of p-S6 signals in Osx-Cre; Tsc1f/f mice suggested an increase in mTOR activation in some of the renal cells (Fig. 4A). Adult Osx-Cre; Tsc1f/f mice showed slightly larger kidney than the littermate controls (Fig. 4B, left panel). The average kidney weight of the Osx-Cre; Tsc1f/f mice was greater than that of the control mice (Fig. 4B, right panel). H-E staining of the Osx-Cre; Tsc1f/f mouse kidney sections revealed multiple cysts of varying sizes at the juxtamedullary cortex (Fig. 4C,D). The average cyst size and ratio of cyst area/tissue area were calculated and both indexes were greater than those of Prx1-Cre; Tsc1f/f mice (Fig. 4E). However, no change in the glomeruli index was observed in Osx-Cre; Tsc1f/f mice (Fig. 4F). Immunostaining revealed that the cysts were positive for Villin, a proximal tubular cell marker, but negative for THP, CD31, WT-1, or vimentin (Fig. 5A). Since Osx labels tubular cells, these results suggest that Tsc1 deletion in tubular cells leads to cyst formation. Note the morphology difference in cysts formed in Prx1-Cre; Tsc1f/f mice and Osx-Cre; Tsc1f/f mice.

Figure 4.

Figure 4

Open in a new tab

Conditional knockout of Tsc1 in the Osx lineage resulted in the development of mTORC1-dependent cysts. (A) Osx-Cre; Tsc1f/ f mouse kidney sections showed increased p-S6 signals. (B) Osx-Cre; Tsc1f/f mice showed enlarged kidneys that were rescued by rapamycin. Left panel: the kidneys of different mouse lines. Right panel: the weights of the kidneys of different mouse lines. (C) H-E staining (4x) of the kidney sections of Osx-Cre; Tsc1f/f and control mice treated with rapamycin or vehicle. (D) Images of kidney sections of Osx-Cre; Tsc1f/f and control mice treated with rapamycin or vehicle. (E) Quantitative data of the cystic index of Osx-Cre; Tsc1f/f and control mice treated with rapamycin or vehicle. The cystic index for control mice is 0. (F) Quantitative analysis of glomerulus separation. N = 3. *P < 0.05; **P < 0.001 when compared to the control mice.

Figure 5.

Figure 5

Open in a new tab

Osx-Cre; Tsc1f/f mouse kidney samples showed increased proliferating cells and apoptotic cells compared to control mice. (A) Immunofluorescent staining for different renal cell markers at the cyst region of Osx-Cre; Tsc1f/f mouse showed that the cysts were only positive for Villin. (B) Representative images of Ki67-staining kidney sections. (C) Quantitative analysis of Ki67 positive cells. (D) Representative images of TUNEL staining kidney sections. Arrows indicate apoptotic cells. (E) Quantitative analysis of TUNEL positive cells. N = 3. *P < 0.05; **P < 0.001 when compared to the control mice.

Rapamycin was given to Osx-Cre; Tsc1f/f mice and control mice daily via intraperitoneal injection for 4 weeks. Kidneys were harvested at the end of the injection. The kidneys of rapamycin-treated Osx-Cre; Tsc1f/f mice appeared to be similar to the normal mice (Fig. 4B). H-E staining showed that rapamycin prevented the development of cysts in Osx-Cre; Tsc1f/f mice (Fig. 4C,D). The average cyst size and the ratio of cystic area to total cortex tissue area were significantly reduced in rapamycin-treated Osx-Cre; Tsc1f/f mice (Fig. 4E). These results suggested that the renal abnormalities observed in Osx-Cre; Tsc1f/f mice were also caused by activated mTORC1.

Osx-Cre; Tsc1f/f mice showed an increase in cell proliferation and apoptosis

Cell proliferation and apoptosis in the kidney of the Osx-Cre; Tsc1f/f mice were also analyzed using Ki67 immunostaining and TUNEL analysis, respectively. An increase in Ki67-positive cells and TUNEL-positive nuclei, after normalized to DAPI-stained nuclei, were observed in the kidney of the Osx-Cre; Tsc1f/f mice compared to control mice (Fig. 5B–E). Again, these results suggested that elevated cell proliferation was involved in the development of cysts in Osx-Cre; Tsc1f/f mice, similar to what was observed in Prx1-Cre; Tsc1f/f mice (Fig. 3B–E).

Dermo1-mediated ablation of Tsc1 failed to produce renal phenotypes

Lastly, we tested the effects of mTOR signaling in Dermo1 lineage cells. A recent study showed that the deletion of Tsc2 in Dermo1 lineage cells led to renal tubular epithelial hyperplasia and ploycystic kidney. The mice died at around 21 days after birth31. We first traced Dermo1 lineage cells in the kidney using Dermo1-Cre; tdTomato mice and found that the number of Dermo1-Cre lineage cells was in general less than that of Prx1 or Osx lineage cells. The signals were detected in both cortex and medulla of the kidney (Fig. 6A). Immuno-staining revealed that Dermo1 lineage cells were negative for Villin, THP, CD31, WT-1, Laminin α5, and vimentin (Fig. 6B), suggesting that Dermo1 lineage may constitute a group of renal stromal cells/fibroblasts.

Figure 6.

Figure 6

Open in a new tab

Conditional knockout of Tsc1 in the Dermo1 lineage did not result in cystogenesis. (A) Microscopic images of kidney sections of Dermo1-Cre; tdTomato mice showed that Dermo1 could label tubular and glomerulus cells in mouse kidney. (B) Immunofluorescent staining on Dermo1-Cre; tdTomato mouse kidney sections revealed that Dermo1 linage renal cells were negative for the tested markers of different renal cell types. (C) Dermo1-Cre; Tsc1f/f mouse kidney sections showed increased p-S6 signals. (D) H-E staining (4x) of the kidney sections of 2-month-old Dermo1-Cre; Tsc1f/f and control mice.

We generated Dermo1-Cre; Tsc1f/f mice. Immunostaining confirmed that the mutant mouse kidney had increased p-S6 signals (Fig. 6C). Surprisingly, the Dermo1-Cre; Tsc1f/f mice were in good health. Histological analysis of the kidney failed to find cyst in 2- or 12-month-old mutant mice (Fig. 6D and data not shown). These results suggested significant functional differences between Tsc1 and Tsc2 in renal cell proliferation and apoptosis when their expression was under the control of Dermo1 promoter.

Discussion

The kidney nephrons contain several types of cells including podocytes, mesangial cells, and endothelial cells in the glomerulus, and tubular epithelial cells in the proximal, loop of Henle, and the distal tubules. In addition, there exist stromal cells/fibroblasts in the kidney, which are less well understood. The nephron cells including glomerulus cells are derived from the Six2-positive lineage whereas the interstitial stromal cells are derived from the Foxd1 lineage. In this study, we found that Prx1 and Dermo1 marked the cells in glomerulus and tubular regions that do not express markers for proximal tubular cells, loop of Henle cells, endothelial cells, mesangial cells, epithelial cells, or podocytes. While the identity of these cells awaits confirmation, these results suggest that they represent a group of stromal cells/fibroblasts. Moreover, Dermo1 lineage cells appear to be less abundant than the Prx1 lineage cells in the kidney. Our study thus identified additional genetic markers that could be used to label renal stromal cells. The relationships between these three markers and Six2 and Foxd1 warrant further investigation.

Although Prx1, Dermo1, and Osx label the MSC-osteoblast lineage in the bone marrow, they label renal cells types that are rather distinct. In bone marrow, MSCs labeled by Prx1 or Dermo1 are believed to be skeletal stem cells32–35, which are responsible for skeletal development and bone remodeling36, in a Osx-dependent manner37,38. Recent studies suggest that Dermo1 may mark only osteoprogenitors but not chondrocytes39,40. Thus Prx1, Dermo1, and Osx label the MSC-osteoblast lineage cells at different stages. However, our study shows that Dermo1 and Prx1 may label renal stromal cells, whereas Osx labels renal tubular cells, which are epithelial cells. The observation that Tsc1 ablation mediated by Prx1-Cre, Dermo1-Cre, and Osx-Cre resulted in different renal phenotypes also suggest that these markers label different cells.

Recent studies have revealed that renal tubular cells possess the potential to trans-differentiate into osteoblast-like cells, which may contribute to the production of kidney stones under conditions such as calcium oxalate kidney stones and hyperoxaluric kidneys41. Our study reveal that MSC-osteoblast lineage markers could label the tubular cells. It is possible that some of renal tubular cells have the same origin as bone marrow MSCs and bear some features of osteoblasts. More importantly, Osx is known to promote calcification in bone tissues. The expression of Osx in renal tubular cells may participate in kidney stone formation.

TSC patients usually display overgrowth in brain, kidney, lung, eye and skin. We show here that Tsc1 deficiency in Osx-labeled tubular cells induces cystogenesis in an mTORC1-dependent manner. The cysts in Osx-Cre;Tsc1f/f mice are numerous and small and are located mainly in the renal cortex. Immunostaining reveals that these cysts are mainly derived from Villin-expressing proximal tubular cells. On the other hand, Tsc1 deficiency in Prx1-labeled cells induces formation of unique cysts, which are rare but large. Immunostaining reveals that these cysts are mainly derived from THP-expressing loop of Henle cells. Since Prx1 lineage cells do not express THP, we conclude that Prx1 lineage cells induce cyst formation in a non-cell-autonomous manner. A previous study reported that ablation of Pkd1, encoding polycystin 1, in renal stromal cells caused progressive cystogenesis in the kidney42. These results, taken together, suggest that mutant Tsc1 and Pkd1 genes in renal stromal cells make an important contribution to cystogenesis. It is conceivable that Tsc1 or Pkd1 mutation in the stromal cells may lead to secretion of pro-growth factors to promote proliferation of renal tubular cells.

A surprising finding is that Dermo1-mediated Tsc1 ablation failed to produce kidney cyst in young or old mice. This is in contrast to a recent study showing that Dermo1-mediated Tsc2 ablation led to cyst formation31. Since the same Dermo1-Cre mouse line was used in both studies, the difference in the mouse phenotypes had to be due to the difference between Tsc1 and Tsc2. Although Tsc1 and Tsc2 form a complex to inhibit the activation of mTOR signaling, they may have different activities that are independent of mTOR. Alternatively, their inhibitory effects on mTORC1 signaling may be different in magnitudes. Indeed, Kwiatkowski. et al. showed that renal tumors were lower in the Tsc1 heterozygous mice compared to Tsc2 heterozygous mice2. Moreover, Tsc2 rather than Tsc1 is the major driver for angiomyolipoma and renal cysts in TSC patients43, and Tsc1 mutations are less common than Tsc2 in TSC patients44. Interestingly, while we confirmed that Tsc1 deficient tubular cells showed enhanced proliferation, we discovered an increase in the number of apoptotic cells in the absence of Tsc1, which may be caused by increased cell proliferation.

In summary, our study uncovers a population of cells in the kidney, stromal cells/fibroblasts, that are be labeled by a MSC marker, Prx1. Ablation of Tsc1 in these cells causes cyst from loop of Henle, which is different from the cyst caused by ablation of Tsc1 in Osx-labeled tubular cells in morphology and origin. These findings suggest stromal cells contribute to cyst formation in TSC patients.

Materials and Methods

Animals

The Prx1-Cre, Osx-Cre, and floxed Tsc1 (iDTR, tomato) mouse lines were originally generated from the Jackson Laboratory. All mice used were crossed and housed in a specific-pathogen-free (SPF) mouse facility under standard conditions in Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.

All animal procedures were carried out following the recommendations from the National Research Council Guide for the Care and Use of Laboratory Animals, with the protocols being approved by the Institutional Animal Care and Use Committee of Shanghai, China [SYXK (SH) 2011-0112]. Unless otherwise specified, mice at the age of 2 months were sacrificed for individual experiment.

Histology, Immunohistochemistry and Immunofluorescent microscopy

Kidneys were harvested immediately after the mice were sacrificed and rinsed in phosphate-buffered saline (PBS) twice before fixed in 4% freshly made paraformaldehyde (PFA). For histological and immunohistochemistry studies, kidneys were embedded in paraffin and sectioned at 5 μm thickness. H-E staining was carried out according to the standard protocol and images were scanned by Olympus DP80 (Olympus Microsystems, San Jose, CA, USA), and photographed by Olympus DP72 (Olympus Microsystems, USA).

For immunofluorescent microscopy, the fixed kidneys were dehydrated by incubating in increasing concentrations of sucrose solutions before being embedded in OCT. The snap-frozen tissues were kept at −80 °C until sectioned. Samples were sliced into 5 μm thickness sections and stained with ProLong Gold DAPI (Life Technologies, New York, USA). Images were taken and analyzed using the Olympus DP72 microscope.

For immunohistochemistry analysis, the tissue sections were deparaffinized in xylene, rehydrated and permeabilized with 0.1% Triton X-100 for 20 mins at room temperature. They were treated with citrate buffer in a pressurized oven for antigen retrieval. Subsequently, the slides were blocked with 10% goat serum in 1x PBS for 1 hour, incubated with specific primary antibody overnight at 4 °C, rinsed in 1x PBS, then incubated with 1% secondary antibody (diluted in 1x PBS) for 1 hour at 37 °C. After brief washing in 1x PBS, slides were incubated in 1% SABC solution for 1 hour at 37 °C.

Renal Cyst Index Measurement

Both kidneys were excised, de-capsulated and the weight was combined. Coronal sections of the inner part of kidney were used for renal cyst index calculation. H-E stained sections were imaged at 100x magnification and used to count the number of glomerulus and cysts, the areas of cysts, renal cortex and the whole kidney. Glomerulus separation was defined as the ratio between the number of glomerulus and renal cortex. The cystic index was defined as the ratio between the combined area of cysts and the area of entire kidney.

Cell apoptosis analysis

In Situ Cell Death Detection Kit (Roche, Basel, Switzerland) was used to examine cell apoptosis. De-waxed and rehydrated kidney sections were incubated with proteinase K working solution (20 µg/ml) for 20 mins at room temperature. The slides were rinsed in 1x PBS and the area surrounding the samples was dried. The TUNEL reaction mixture was added to the tissue slides and they were incubated in a humidified chamber for 1 hour at 37 °C. After the incubation, the slides were rinsed and the imaged directly under a Nikon ECLIPSE Ti fluorescence microscope (Nikon, Tokyo, Japan).

Rapamycin Treatment

Rapamycin (3 μg/g body weight in 500 ng/µl) or vehicle at the same volume was injected daily into mouse abdomen for 4 weeks. Mice were sacrificed three days after the last injection.

Statistical Analysis

All experiments were repeated at least three times and the averaged data ± standard deviation (SD) were presented. Students’ unpaired t-tests were performed to compare data between groups and the difference was considered significant if the p value equals or was less than 0.05.

Acknowledgements

The work was supported by the National Natural Science Foundation of China (81570829).

Author Contributions

Z.W., H.W., S.U.M., G.Y., performed the experiments, S.L.H., B.L. and J.L. designed the experiments and wrote the manuscript.

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Bonnet CS, et al. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis. Hum Mol Genet. 2009;18:2166–2176. doi: 10.1093/hmg/ddp149. [DOI] [PubMed] [Google Scholar]
  • 2.Kwiatkowski DJ, et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet. 2002;11:525–534. doi: 10.1093/hmg/11.5.525. [DOI] [PubMed] [Google Scholar]
  • 3.Zhou J, Brugarolas J, Parada LF. Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1. Hum Mol Genet. 2009;18:4428–4441. doi: 10.1093/hmg/ddp398. [DOI] [PubMed] [Google Scholar]
  • 4.von Ranke FM, et al. Imaging of tuberous sclerosis complex: a pictorial review. Radiol Bras. 2017;50:48–54. doi: 10.1590/0100-3984.2016.0020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kato I, et al. Epithelioid angiomyolipoma of the kidney. Pathol Int. 2009;59:38–43. doi: 10.1111/j.1440-1827.2008.02322.x. [DOI] [PubMed] [Google Scholar]
  • 6.Huber TB, Walz G, Kuehn EW. mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney Int. 2011;79:502–511. doi: 10.1038/ki.2010.457. [DOI] [PubMed] [Google Scholar]
  • 7.Brook-Carter PT, et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease-a contiguous gene syndrome. Nat Genet. 1994;8:328–332. doi: 10.1038/ng1294-328. [DOI] [PubMed] [Google Scholar]
  • 8.Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 2009;76:149–168. doi: 10.1038/ki.2009.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kandt RS, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet. 1992;2:37–41. doi: 10.1038/ng0992-37. [DOI] [PubMed] [Google Scholar]
  • 10.Wahl PR, et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD) Nephrol Dial Transplant. 2006;21:598–604. doi: 10.1093/ndt/gfi181. [DOI] [PubMed] [Google Scholar]
  • 11.Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. The Lancet. 2007;369:1287–1301. doi: 10.1016/S0140-6736(07)60601-1. [DOI] [PubMed] [Google Scholar]
  • 12.Jones AC, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet. 1999;64:1305–1315. doi: 10.1086/302381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pema M, et al. mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex. Nat Commun. 2016;7:10786. doi: 10.1038/ncomms10786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.D’Armiento J, et al. Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation. Cancer Res. 2016;76:844–854. doi: 10.1158/0008-5472.CAN-15-1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Al-Awqati Q. Kidney growth and hypertrophy: the role of mTOR and vesicle trafficking. J ClinInvest. 2015;125:2267. doi: 10.1172/JCI81508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kobayashi A, et al. Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Rep. 2014;3:650–662. doi: 10.1016/j.stemcr.2014.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mugford JW, Sipila P, McMahon JA, McMahon AP. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol. 2008;324:88–98. doi: 10.1016/j.ydbio.2008.09.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Disthabanchong S, Radinahamed P, Stitchantrakul W, Hongeng S, Rajatanavin R. Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. Kidney Int. 2007;71:201–209. doi: 10.1038/sj.ki.5002035. [DOI] [PubMed] [Google Scholar]
  • 19.Evan AP, et al. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken) 2015;298:865–877. doi: 10.1002/ar.23105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jia Z, et al. Role of calcium in the regulation of bone morphogenetic protein 2, runt-related transcription factor 2 and Osterix in primary renal tubular epithelial cells by the vitamin D receptor. Mol Med Rep. 2015;12:2082–2088. doi: 10.3892/mmr.2015.3568. [DOI] [PubMed] [Google Scholar]
  • 21.ten Berge D, Brouwer A, Korving J, Martin JF, Meijlink F. Prx1 and Prx2 in skeletogenesis: roles in the craniofacial region, inner ear and limbs. Development. 1998;125:3831–3842. doi: 10.1242/dev.125.19.3831. [DOI] [PubMed] [Google Scholar]
  • 22.Lu X, et al. Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor alpha action in osteoblast differentiation. J Bone Miner Res. 2011;26:209–219. doi: 10.1002/jbmr.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lee MS, Lowe G, Flanagan S, Kuchler K, Glackin CA. Human Dermo-1 Has Attributes Similar to Twist in Early Bone Development. Bone. 2000;27:591–602. doi: 10.1016/S8756-3282(00)00380-X. [DOI] [PubMed] [Google Scholar]
  • 24.Tamura M, Noda M. Identification of DERMO-1 as a Member of Helix-Loop-Helix Type Transcription Factors Expressed in Osteoblastic Cells. J Cell Biochem. 1999;72:167–176. doi: 10.1002/(SICI)1097-4644(19990201)72:2&#x0003c;167::AID-JCB1&#x0003e;3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  • 25.Wu H, et al. Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and Osteoclasts. Stem Cell Rep. 2017;8:1600–1616. doi: 10.1016/j.stemcr.2017.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Aoki R, et al. Foxl1-expressing mesenchymal cells constitute the intestinal stem cell niche. Cell Mol Gastroenterol Hepatol. 2016;2:175–188. doi: 10.1016/j.jcmgh.2015.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.van Blijswijk J, et al. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. J Immunol. 2015;194:307–315. doi: 10.4049/jimmunol.1401999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Buch, T. et al. A cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods. 2(6), 419–26 (2005). [DOI] [PubMed]
  • 29.Strecker S, Fu Y, Liu Y, Maye P. Generation and characterization of Osterix-Cherry reporter mice. Genesis. 2013;51:246–258. doi: 10.1002/dvg.22360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Baek WY, et al. Persistent low level of osterix accelerates interleukin-6 production and impairs regeneration after tissue injury. PLoS One. 2013;8:e69859. doi: 10.1371/journal.pone.0069859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ren S, et al. Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization. Am J Pathol. 2016;186:3261–3272. doi: 10.1016/j.ajpath.2016.08.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Cong Q, et al. p38alpha MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. Stem Cell Rep. 2016;6:566–578. doi: 10.1016/j.stemcr.2016.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Li L, Cserjesi P, Olson EN. Dermo-1: A Novel Twist-Related bHLH Protein Expressed in the Developing Dermis. Dev Biol. 1995;172:280–292. doi: 10.1006/dbio.1995.0023. [DOI] [PubMed] [Google Scholar]
  • 34.Mendez-Ferrer S, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466:829–834. doi: 10.1038/nature09262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell. 2014;15:154–168. doi: 10.1016/j.stem.2014.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bruder SP, Fink DJ, Caplan AI. Mesenchymal Stem Cells in Bone Developmet, Bone Repair, and Skeletal Regeneration Therapy. J Cell Biochem. 1994;56:283–294. doi: 10.1002/jcb.240560303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nakashima K, et al. The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation. Cell. 2002;108:17–29. doi: 10.1016/S0092-8674(01)00622-5. [DOI] [PubMed] [Google Scholar]
  • 38.Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 2006;99:1233–1239. doi: 10.1002/jcb.20958. [DOI] [PubMed] [Google Scholar]
  • 39.Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. P Natl Acad Sci USA. 2004;101:12555–12560. doi: 10.1073/pnas.0405031101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Tran TH, et al. Role of canonical Wnt signaling/ss-catenin via Dermo1 in cranial dermal cell development. Development. 2010;137:3973–3984. doi: 10.1242/dev.056473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Joshi S, Clapp WL, Wang W, Khan SR. Osteogenic changes in kidneys of hyperoxaluric rats. Biochim Biophys Acta. 2015;1852:2000–2012. doi: 10.1016/j.bbadis.2015.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nie X, Arend LJ. Deletion of Pkd1 in renal stromal cells causes defects in the renal stromal compartment and progressive cystogenesis in the kidney. Lab Invest. 2017;97:1427–1438. doi: 10.1038/labinvest.2017.97. [DOI] [PubMed] [Google Scholar]
  • 43.Giannikou K, et al. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. PLoS Genet. 2016;12:e1006242. doi: 10.1371/journal.pgen.1006242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dabora SL, et al. Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs. Am J Hum Genet. 2001;68:64–80. doi: 10.1086/316951. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES